Peptides work at the cellular level to enhance your bodys natural repair and regeneration processes, providing more comprehensive and long-lasting results than treatments that only address surface-level concerns
The good news of the month- Latest pancreatic cancer research shows potential to shrink and eliminate tumors A research team led by Mariano Barbacid at the Spanish National Cancer Research Centre (CNIO) has developed an experimental triple-combination therapy that completely eliminated pancreatic tumors in mice with no major side effects
| Updated for New York patients Understanding potential side effects is part of making an informed decision about any peptide therapy
KLOW is a precision co-lyophilized four-component peptide research blend supplied exclusively for laboratory and preclinical research applications
The pharmacogenomics of GLP-1 agonists (like Ozempic and Wegovy), including their contraindications for patients with RET mutations
A pooled analysis of the STEP 1-3 clinical trials found nausea affected roughly 44% of participants on semaglutide 2.4 mg, with most GI symptoms mild to moderate and concentrated in the first weeks of treatment
